Suppr超能文献

小叶原位癌和浸润性小叶癌的靶向捕获大规模平行测序分析:体细胞基因改变谱和克隆关系

Targeted capture massively parallel sequencing analysis of LCIS and invasive lobular cancer: Repertoire of somatic genetic alterations and clonal relationships.

作者信息

Sakr Rita A, Schizas Michail, Carniello Jose V Scarpa, Ng Charlotte K Y, Piscuoglio Salvatore, Giri Dilip, Andrade Victor P, De Brot Marina, Lim Raymond S, Towers Russell, Weigelt Britta, Reis-Filho Jorge S, King Tari A

机构信息

Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, United States.

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, United States.

出版信息

Mol Oncol. 2016 Feb;10(2):360-70. doi: 10.1016/j.molonc.2015.11.001. Epub 2015 Nov 14.

Abstract

PURPOSE

Lobular carcinoma in situ (LCIS) has been proposed as a non-obligate precursor of invasive lobular carcinoma (ILC). Here we sought to define the repertoire of somatic genetic alterations in pure LCIS and in synchronous LCIS and ILC using targeted massively parallel sequencing.

METHODS

DNA samples extracted from microdissected LCIS, ILC and matched normal breast tissue or peripheral blood from 30 patients were subjected to massively parallel sequencing targeting all exons of 273 genes, including the genes most frequently mutated in breast cancer and DNA repair-related genes. Single nucleotide variants and insertions and deletions were identified using state-of-the-art bioinformatics approaches.

RESULTS

The constellation of somatic mutations found in LCIS (n = 34) and ILC (n = 21) were similar, with the most frequently mutated genes being CDH1 (56% and 66%, respectively), PIK3CA (41% and 52%, respectively) and CBFB (12% and 19%, respectively). Among 19 LCIS and ILC synchronous pairs, 14 (74%) had at least one identical mutation in common, including identical PIK3CA and CDH1 mutations. Paired analysis of independent foci of LCIS from 3 breasts revealed at least one common mutation in each of the 3 pairs (CDH1, PIK3CA, CBFB and PKHD1L1).

CONCLUSION

LCIS and ILC have a similar repertoire of somatic mutations, with PIK3CA and CDH1 being the most frequently mutated genes. The presence of identical mutations between LCIS-LCIS and LCIS-ILC pairs demonstrates that LCIS is a clonal neoplastic lesion, and provides additional evidence that at least some LCIS are non-obligate precursors of ILC.

摘要

目的

小叶原位癌(LCIS)被认为是浸润性小叶癌(ILC)的非必然前体。在此,我们试图通过靶向大规模平行测序来确定纯LCIS以及同步发生的LCIS和ILC中的体细胞基因改变情况。

方法

从30例患者的显微切割的LCIS、ILC以及匹配的正常乳腺组织或外周血中提取的DNA样本,进行针对273个基因所有外显子的大规模平行测序,这些基因包括乳腺癌中最常发生突变的基因以及与DNA修复相关的基因。使用最先进的生物信息学方法鉴定单核苷酸变异以及插入和缺失。

结果

在LCIS(n = 34)和ILC(n = 21)中发现的体细胞突变情况相似,最常发生突变的基因分别是CDH1(分别为56%和66%)、PIK3CA(分别为41%和52%)和CBFB(分别为12%和19%)。在19对同步发生的LCIS和ILC中,14对(74%)至少有一个相同的突变,包括相同的PIK3CA和CDH1突变。对来自3例乳腺的LCIS独立病灶进行配对分析,发现3对中的每一对都至少有一个共同突变(CDH1、PIK3CA、CBFB和PKHD1L1)。

结论

LCIS和ILC具有相似的体细胞突变情况,PIK3CA和CDH1是最常发生突变的基因。LCIS-LCIS对和LCIS-ILC对之间存在相同突变,表明LCIS是一种克隆性肿瘤性病变,并提供了额外证据,证明至少一些LCIS是ILC的非必然前体。

相似文献

2
PIK3CA mutations are common in lobular carcinoma in situ, but are not a biomarker of progression.
Breast Cancer Res. 2017 Jan 17;19(1):7. doi: 10.1186/s13058-016-0789-y.
4
Gene expression profiling of lobular carcinoma in situ reveals candidate precursor genes for invasion.
Mol Oncol. 2015 Apr;9(4):772-82. doi: 10.1016/j.molonc.2014.12.005. Epub 2014 Dec 24.
5
Germline CDH1 mutations in bilateral lobular carcinoma in situ.
Br J Cancer. 2014 Feb 18;110(4):1053-7. doi: 10.1038/bjc.2013.792. Epub 2013 Dec 24.
6
Clonality of lobular carcinoma in situ (LCIS) and metachronous invasive breast cancer.
Breast Cancer Res Treat. 2008 Feb;107(3):331-5. doi: 10.1007/s10549-007-9557-0. Epub 2007 Mar 23.
7
Lobular Carcinomas Display Intralesion Genetic Heterogeneity and Clonal Evolution in the Progression to Invasive Lobular Carcinoma.
Clin Cancer Res. 2019 Jan 15;25(2):674-686. doi: 10.1158/1078-0432.CCR-18-1103. Epub 2018 Sep 5.
8
Clonality of lobular carcinoma in situ and synchronous invasive lobular carcinoma.
Cancer. 2004 Jun 15;100(12):2562-72. doi: 10.1002/cncr.20273.

引用本文的文献

1
Surgery for Classic, Pleomorphic and Non-classic Lobular Carcinoma In Situ: Surgery Rate, Risk of Upstaging and Short-Term Follow-Up.
Ann Surg Oncol. 2025 Apr;32(4):2545-2553. doi: 10.1245/s10434-024-16686-8. Epub 2024 Dec 30.
2
Absence of lobular carcinoma in situ is a poor prognostic marker in invasive lobular carcinoma.
Eur J Cancer. 2023 Sep;191:113250. doi: 10.1016/j.ejca.2023.113250. Epub 2023 Jul 22.
3
An update on intraductal and intralobular proliferative lesions of the breast.
Rev Assoc Med Bras (1992). 2023 Aug 4;69(suppl 1):e2023S121. doi: 10.1590/1806-9282.2023S121. eCollection 2023.
4
Update on lobular lesions of the breast.
Histopathology. 2023 Jan;82(1):36-52. doi: 10.1111/his.14829.
5
Comparison of the Imaging Features of Lobular Carcinoma In Situ and Invasive Lobular Carcinoma of the Breast.
Taehan Yongsang Uihakhoe Chi. 2021 Sep;82(5):1231-1245. doi: 10.3348/jksr.2020.0148. Epub 2021 Jul 2.
6
Lobular Breast Cancer: Histomorphology and Different Concepts of a Special Spectrum of Tumors.
Cancers (Basel). 2021 Jul 22;13(15):3695. doi: 10.3390/cancers13153695.
7
Lobular carcinoma in situ: diagnostic criteria and molecular correlates.
Mod Pathol. 2021 Jan;34(Suppl 1):8-14. doi: 10.1038/s41379-020-00689-3. Epub 2020 Oct 6.
8
Somatic genetic aberrations in benign breast disease and the risk of subsequent breast cancer.
NPJ Breast Cancer. 2020 Jun 12;6:24. doi: 10.1038/s41523-020-0165-z. eCollection 2020.
9
American Registry of Pathology Expert Opinions: The Spectrum of Lobular Carcinoma in Situ: Diagnostic Features and Clinical Implications.
Ann Diagn Pathol. 2020 Apr;45:151481. doi: 10.1016/j.anndiagpath.2020.151481. Epub 2020 Feb 15.

本文引用的文献

1
Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer.
Cell. 2015 Oct 8;163(2):506-19. doi: 10.1016/j.cell.2015.09.033.
2
Molecular drivers of lobular carcinoma in situ.
Breast Cancer Res. 2015 Jun 4;17:76. doi: 10.1186/s13058-015-0580-5.
5
Hotspot activating PRKD1 somatic mutations in polymorphous low-grade adenocarcinomas of the salivary glands.
Nat Genet. 2014 Nov;46(11):1166-9. doi: 10.1038/ng.3096. Epub 2014 Sep 21.
6
PI3K pathway activation in high-grade ductal carcinoma in situ--implications for progression to invasive breast carcinoma.
Clin Cancer Res. 2014 May 1;20(9):2326-37. doi: 10.1158/1078-0432.CCR-13-2267. Epub 2014 Mar 14.
7
Characterization of the genomic features and expressed fusion genes in micropapillary carcinomas of the breast.
J Pathol. 2014 Apr;232(5):553-65. doi: 10.1002/path.4325. Epub 2014 Feb 5.
8
Discovery and saturation analysis of cancer genes across 21 tumour types.
Nature. 2014 Jan 23;505(7484):495-501. doi: 10.1038/nature12912. Epub 2014 Jan 5.
9
Mutational landscape and significance across 12 major cancer types.
Nature. 2013 Oct 17;502(7471):333-339. doi: 10.1038/nature12634.
10
Lobular neoplasia of the breast revisited with emphasis on the role of E-cadherin immunohistochemistry.
Am J Surg Pathol. 2013 Jul;37(7):e1-11. doi: 10.1097/PAS.0b013e3182918a2b.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验